You are here

One in three South Korean Covid-19 patients improve with remdesivir

AB_remdesivir_130720.jpg
One in three South Korean patients seriously ill with Covid-19 showed an improvement in their condition after being given Gilead Sciences Inc's antiviral remdesivir, health authorities said.

[SEOUL] One in three South Korean patients seriously ill with Covid-19 showed an improvement in their condition after being given Gilead Sciences Inc's antiviral remdesivir, health authorities said.

More research was needed to determine if the improvement was attributable to the drug or...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes